Related Experiment Video
Updated: Feb 24, 2026
09:20
Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
3.6K
A Functional Assay for Sick Sinus Syndrome Genetic Variants
Chuanchau J Jou1, Cammon B Arrington2, Spencer Barnett2
1Division of Pediatric Cardiology, Cleveland Clinic, Cleveland, Utah, USA.
Summary
Zebrafish models effectively identify disease-causing mutations in the HCN4 gene, linked to congenital Sick Sinus Syndrome (SSS). This assay provides a novel tool for understanding SSS and predicting patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Developmental Biology
Background:
- Congenital Sick Sinus Syndrome (SSS) is a genetic disorder causing severe bradycardia and cardiac pauses, increasing the risk of sudden cardiac death.
- Mutations in the HCN4 gene, responsible for the If ion channel, are a known cause of congenital SSS.
Purpose of the Study:
- To establish an embryonic zebrafish model for congenital Sick Sinus Syndrome (SSS).
- To utilize zebrafish as a moderate-throughput screening assay for functional characterization of HCN4 variants.
Main Methods:
- Zebrafish embryos were treated with an If-specific blocker (ZD-7288) or underwent knockdown of endogenous hcn4 using morpholinos.
- The study evaluated four known pathogenic HCN4 mutations and four variants of unknown significance (VUS) to validate the zebrafish model's accuracy.
Main Results:
- Pharmacological blockade and hcn4 knockdown in zebrafish successfully replicated SSS phenotypes, including bradycardia and cardiac pauses.
- The zebrafish assay accurately identified all disease-causing HCN4 mutations.
- Among VUS, the assay classified two as benign and two as hypomorphic.
Conclusions:
- The developed embryonic zebrafish assay is a novel and effective method for the functional assessment of human HCN4 variants.
- This assay has the potential to provide valuable clinical prognostic information for patients with SSS.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
31
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
31
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
26
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
26
01:05Single Nucleotide Polymorphisms-SNPs
18.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.7K
01:30Dysrhythmias V: Evaluating Dysrhythmias
414
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
414